I stop scoring when a candidate draws a 2×2, labels the four boxes, and waits for applause. The Ansoff matrix is on the sheet as a tool: does it help you size and rank growth options under uncertainty? Naming market penetration does not.
H. Igor Ansoff did not publish a parlor trick. In Strategies for Diversification (Harvard Business Review, 1957, pp. 113–124), he defined four product-market paths and then insisted on a qualitative screen followed by a return measure. After this piece you should be able to use that logic in a live case: map the client's actual ideas, kill the grid when it is the wrong tree, and put contribution on every path before you recommend a sequence.
What Ansoff actually wrote in 1957
The classroom 2×2 you memorized is usually traced to Ansoff's later book Corporate Strategy (McGraw-Hill, 1965). The four growth alternatives already appear in the 1957 HBR article: market penetration, market development, product development, and diversification.
Ansoff's definitions are sharper than the flashcard versions:
| Path | Ansoff's idea (1957) | What you already know | What you must invent |
|---|---|---|---|
| Market penetration | More sales without leaving the current product-market strategy | Product, cost, channel, buyers | Share, frequency, unused capacity |
| Market development | Adapt the present line to new missions | Product and cost | Buyer, channel, landed economics |
| Product development | New product characteristics for the present mission | Relationships and mission | Spec, attach, incremental margin |
| Diversification | Simultaneous departure from product line and market structure | Almost nothing transferable | Skills, facilities, returns, and why you belong |
Two lines from him matter more than the box names. First, diversification "almost invariably leads to physical and organizational changes" and needs "new skills, new techniques, and new facilities" — so treating a bolt-on acquisition as "just another growth idea" is a category error. Second, after qualitative screening he wants a return measure (he works with expected present value of incremental return on investment) to narrow the remaining strategies. The interview translation is blunt: labels are free; contribution is the score.
You almost never need to say "Ansoff." Say: "I would separate selling more of what we already make to current buyers, taking that product to a new geography or mission, launching a new spec to people we already serve, and only then a true new-business bet — then put euros or dollars on each."
Where the matrix fails in a live case
The fail mode is not "forgot diversification." It is deploying the grid when the case is not a growth-option problem.
Profitability first. Volume flat, margin down, fixed costs sticky: the interviewer wants a profit bridge, not four growth slogans. Filling idle capacity at a thin contribution can make the P&L worse. Use a profitability tree before you open Ansoff.
Single-SKU pricing or mix. "Should we raise price 4%?" is not a product-market strategy choice. Drawing market development on the whiteboard burns clock.
Forced move. A lost license, a ban, or a sole-source customer exiting is not optional diversification. Four boxes of voluntary growth are decoration.
Org and capability cases. When the prompt is "why does execution fail across business units," reach for something like 7S, not a growth vector.
The failure unique to this grid is treating "new market" as automatically larger. Candidates hear "export" or "Southeast" and invent TAM. In bulk or freight-heavy goods, landed cost versus local price is the whole case. The other unique fail is parking a related-adjacent acquisition in diversification and then doing no returns math. If both product and market are new, you owe a price, a synergy story, and an integration risk — or you say "out of scope for a growth sequence" and move on. For true M&A mechanics, switch trees to an M&A framework.
Ned's rule. If you cannot put a contribution or payback on each Ansoff cell in under two minutes, you are reciting, not analyzing. Empty boxes score like empty MECE: neat, and zero.
Worked example: Clearline Gaskets sizes four bets
Prompt. Clearline makes food-grade silicone gaskets for beverage bottlers on the U.S. West Coast. Revenue $48m. Volume 20 million units. ASP $2.40. Variable cash cost $1.10. Contribution $1.30 per unit. Fixed costs $14m. The category at current customers is about 55 million units per year; Clearline's share is ~36%. Management wants "a growth strategy" and has four ideas on the whiteboard: push share with current bottlers, enter Southeast bottling plants with the same SKUs, launch a CIP-compatible sanitizer gasket to existing West Coast accounts, and acquire a regional clean-in-place chemical distributor.
Map the ideas. Then kill with arithmetic.
Market penetration (same product, same market). A realistic share fight might lift share from 36% to 40% — about 2.2 million incremental units if the category holds. At $1.30 that is $2.9m contribution before extra selling cost. Assume $0.6m of targeted discounts and field time. Year-1 net ~$2.3m. Caveat: competitors will respond; you should flag price risk on the existing 20 million units. Still, the unknowns are few: same buyers, same plant, same freight.
Market development (same product, new market). Southeast TAM for the same gasket type: say 40 million units. Realistic year-1 capture with two distributors: 6% = 2.4 million units. Landed variable cost rises $0.25 for freight and distributor margin, so contribution falls to $1.05. Gross contribution $2.5m. One-time warehouse and launch $1.1m. Year-1 net ~$1.4m. The number looks fine until you ask whether Southeast OEMs already have preferred specs and dual-source contracts. You are the swing supplier until you prove reliability.
Product development (new product, same market). Sanitizer gasket sold to the same West Coast bottlers. Install base you already serve: 20 million units of legacy gasket. Attach rate in a 12-month trial: 18% of units get a companion sanitizer SKU (3.6 million). ASP $3.10, variable cost $1.55, contribution $1.55. Incremental contribution $5.6m. Tooling and trial $0.9m. Year-1 net ~$4.7m. This uses relationships and a mission you already fulfill — Ansoff's product-development path — and it is the cheapest learning loop (90-day site trials with named accounts).
Diversification (new product, new market). The CIP chemical distributor does trucks, dosing, and accounts Clearline does not serve. Asking price $18m at ~7× EBITDA. Synergies claimed: "cross-sell gaskets into chem accounts." Even if you attach $4m of gasket revenue at $1.30 contribution ($5.2m), you still need the chem business itself to earn its keep, and you have bought a different operating model. For a growth-sequence case, park it: it is a corporate-scope bet, not a gasket growth lever. Contemporary strategy writing still treats diversification as the high-risk move that can "pull your company apart" if it does not strengthen the core — see HBR's 2024 note on diversifying — which matches Ansoff's 1957 warning about new skills and facilities.
Rank and recommend.
| Option | Path | Year-1 net (illustrative) | Main unknown | Rank |
|---|---|---|---|---|
| Sanitizer gasket attach | Product development | ~$4.7m | Attach rate sticks past trial | 1 |
| West Coast share push | Penetration | ~$2.3m | Price war on base volume | 2 |
| Southeast launch | Market development | ~$1.4m | Spec lock-in and dual source | 3 |
| CIP distributor buy | Diversification | Not a gasket growth bet | Integration + unrelated ops | 4 / park |
Recommendation: trial the sanitizer gasket with the top 12 West Coast bottlers in 90 days; fund a measured share push only if price floors hold; treat Southeast as a second wave after attach data; do not buy the distributor in this case. Risk: procurement awards only on legacy gasket price and attach never materializes. Next step: three named plants, one line trial each, attach measured in units not anecdotes.
Notice what scored: the candidate used Ansoff to organize options, then replaced labels with contribution, one-time cost, and rank. That is the interviewer-side difference between a framework recital and a tool.
How to open the case in sixty seconds
- Restate the growth ask and list the client's actual ideas, not textbook boxes.
- Tag each idea by what is new: product, market/mission, both, or neither.
- Put a contribution (or simple payback) on the cheapest test first.
- Sequence: cheap tests that reuse what you already know, then optional new–new.
- Say what you would kill and why — empty politeness across all four boxes is a soft fail.
If the interviewer hands you only one vague prompt ("how should we grow?"), invent the four paths yourself, then immediately ask for the data that turns them into numbers: share, attach, freight, and capacity. A structure drill will punish a labelled 2×2 with no figure attached.
Practice this today
Open a revenue-growth case and force yourself to build an Ansoff table with four rows and one contribution column before you recommend. Do not name the matrix aloud unless the interviewer asks. Time yourself: two minutes to map, three minutes to math, one minute to rank.
On CoachNed, start with a five-minute typed case at /start (no account), or run a full voice case at /interview. Everything is open for seven days, no card; then $120 for a recruiting season or $49 a month. Pair this with a revenue growth tree so volume, mix, and price sit under the right Ansoff cell, and keep units on every line with the consulting math habits.
CoachNed is not affiliated with McKinsey, BCG, Bain, Deloitte, or any firm named in interview folklore.
Frequently asked questions
What is the Ansoff matrix in a case interview?
It is a product-market growth map: sell more of the current offer to current buyers, take that offer to a new market or mission, invent a new offer for current buyers, or do both at once (diversification). Interviewers care whether you use it to size and sequence options, not whether you recite the names.
Who invented the Ansoff matrix?
H. Igor Ansoff laid out the four growth alternatives in his 1957 Harvard Business Review article Strategies for Diversification. The familiar 2×2 form is associated with his 1965 book Corporate Strategy; both sources stress evaluation beyond labels.
When should I not use the Ansoff matrix?
Skip it as the first tree on profitability, pricing-only, organization, or forced-move cases. Use it when the prompt is explicitly about choosing or sequencing growth paths with different degrees of newness.
Do I need to say "Ansoff" out loud?
No. Map the four paths in plain language, put numbers on them, and recommend a sequence. Name-dropping without contribution usually scores worse than silent, correct math.
How is Ansoff different from a revenue tree?
A revenue tree decomposes growth into volume, mix, and price for a defined scope. Ansoff chooses which product-market scopes to pursue. Use Ansoff to pick the bets; use a revenue or value chain logic to pressure-test how each bet earns.
Sources
- Strategies for Diversification (Ansoff, HBR 1957 PDF) — primary text for the four product-market strategies and the qualitative-then-return evaluation method. Checked 2026-09-24.
- Corporate Strategy (Ansoff, 1965) — Google Books record — later book commonly linked to the classroom 2×2 form of the growth vector. Checked 2026-09-24.
- Corporate Strategy on Internet Archive — bibliographic confirmation of the 1965 McGraw-Hill edition. Checked 2026-09-24.
- 4 Rules for Diversifying Your Business (HBR, 2024) — contemporary discussion of diversification risk versus sticking to the core. Checked 2026-09-24.